Document Detail


Effects of rehabilitative exercise on peripheral muscle TNFalpha, IL-6, IGF-I and MyoD expression in patients with COPD.
MedLine Citation:
PMID:  17573449     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Skeletal muscle wasting commonly occurs in patients with chronic obstructive pulmonary disease (COPD) and has been associated with the presence of systemic inflammation. This study investigated whether rehabilitative exercise training decreases the levels of systemic or local muscle inflammation or reverses the abnormalities associated with muscle deconditioning. METHODS: Fifteen patients with COPD (mean (SE) forced expiratory volume in 1 s 36 (4)% predicted) undertook high-intensity exercise training 3 days/week for 10 weeks. Before and after the training programme the concentration of tumour necrosis factor alpha (TNFalpha), interleukin-6 (IL-6) and C-reactive protein (CRP) in plasma was determined by ELISA, and vastus lateralis mRNA expression of TNFalpha, IL-6, total insulin-like growth factor-I (IGF-I) and its isoform mechanogrowth factor (MGF) and myogenic differentiation factor D (MyoD) were assessed by real-time PCR. Protein levels of TNFalpha, IGF-I and MyoD were measured by Western blotting. RESULTS: Rehabilitation improved peak exercise work rate by 10 (2%) (p = 0.004) and mean fibre cross-sectional area from 4061 (254) microm(2) to 4581 (241) microm(2) (p = 0.001). Plasma inflammatory mediators and vastus lateralis expression of TNFalpha and IL-6 were not significantly modified by training. In contrast, there was a significant increase in mRNA expression of IGF-I (by 67 (22)%; p = 0.044), MGF (by 67 (15)%; p = 0.002) and MyoD (by 116 (30)%; p = 0.001). The increase observed at the mRNA level was also seen at the protein level for IGF-I (by 72 (36)%; p = 0.046) and MyoD (by 67 (21)%; p = 0.012). CONCLUSIONS: Pulmonary rehabilitation can induce peripheral muscle adaptations and modifications in factors regulating skeletal muscle hypertrophy and regeneration without decreasing the levels of systemic or local muscle inflammation.
Authors:
Ioannis Vogiatzis; Grigoris Stratakos; Davina C M Simoes; Gerasimos Terzis; Olga Georgiadou; Charis Roussos; Spyros Zakynthinos
Related Documents :
8014469 - Immunolocalization of amp-deaminase isozymes in human skeletal muscle and cultured musc...
19748969 - Role of exercise-induced brain-derived neurotrophic factor production in the regulation...
11146509 - Identification and characterization of newt rad (ras associated with diabetes), a gene ...
8335189 - Heterogeneous isoactin gene expression in the adult rat gastrointestinal tract.
9196039 - Ucp3: an uncoupling protein homologue expressed preferentially and abundantly in skelet...
15533719 - Igf2 antisense transcript expression in porcine postnatal muscle is affected by a quant...
8727019 - Controlled active mobilization following surgical repair of the avulsed radial attachme...
7691899 - Peripheral peptidergic fibers of the trigeminal nerve in the olfactory bulb of the rat.
4777709 - The number of muscarinic receptors in chick amnion muscle.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2007-06-15
Journal Detail:
Title:  Thorax     Volume:  62     ISSN:  0040-6376     ISO Abbreviation:  Thorax     Publication Date:  2007 Nov 
Date Detail:
Created Date:  2007-10-29     Completed Date:  2008-01-23     Revised Date:  2010-11-02    
Medline Journal Info:
Nlm Unique ID:  0417353     Medline TA:  Thorax     Country:  England    
Other Details:
Languages:  eng     Pagination:  950-6     Citation Subset:  IM    
Affiliation:
National and Kapodistrian University of Athens - Thorax Foundation, 3 Ploutarhou Str 106 75, Athens, Greece. gianvog@phed.uoa.gr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Exercise Therapy*
Female
Forced Expiratory Volume / physiology
Humans
Insulin-Like Growth Factor I / metabolism*
Interleukin-6 / metabolism
Male
Muscle, Skeletal / metabolism*
MyoD Protein / metabolism*
Pulmonary Disease, Chronic Obstructive / metabolism*,  rehabilitation
RNA, Messenger / metabolism
Tumor Necrosis Factor-alpha / metabolism*
Vital Capacity
Chemical
Reg. No./Substance:
0/Interleukin-6; 0/MyoD Protein; 0/RNA, Messenger; 0/Tumor Necrosis Factor-alpha; 67763-96-6/Insulin-Like Growth Factor I

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Oxidative stress in the external intercostal muscles of patients with obstructive sleep apnoea.
Next Document:  Cancer-related fatigue: the scale of the problem.